Search by Blog
Read by Category

Your healing journey continues beyond this blog

Find the right products for better recovery at online store
Cart Image
US Patent Granted for a Novel Haemostatic Device

Patent No.: US 10,124,084 B2
Date of the Patent Granted: Nov. 13, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE DEVICE AND A METHOD OF PREPARATION THEREOF

Background of the Invention:
Haemostatic products are the agents which promote haemostasis (stop bleeding). These can be used for both surgical or traumatic wounds. Heavy blood loss from the wounds may result in a hypovolemic shock (when the body loses one-fifth of its blood and heart is not able to pump sufficient amount of blood to the body) leading to tissue and organ damage.

Several active ingredients are used in the manufacturing of haemostatic products. These ingredients like Thrombin, Gelatin, Collagen, Fibrin, Synthetic, etc. help to accelerate the process the haemostasis. Several products are available in the market but none of these products comprise of the active ingredients and the method to prepare the same as covered in the present invention.

 Summary of the Invention:
The innovative product described in this patent is a ready to use biodegradable and biocompatible device used to stop wound bleeding and a method of preparation thereof.

The invention is a device comprising of a novel porous scaffold of an absorbent gelatin-chitosan Polyelectrolyte complex (GCPEC) which quickly stops bleeding from any type of wounds, i.e. surgical or non-surgical. This innovative device is developed with a combined application of air dry and freeze dry method.

This sterile dressing product carries the therapeutic and bioactive molecules with preference to accelerate the process of stopping the bleeding of the wounds.

The device has excellent ventilation features which prevent infections which may be caused due to bleeding. Further, the scaffold under the present invention comprises of differential porosity and regulated pores on the same platform in a molecularly integrated PEG matrix.

Advantages of the Invention:

  • Ready – to – use bandage for stopping bleeding of wounds and prevents from loss of life due bleeding.
  • The present invention stops bleeding within few minutes.
    • requires less time to stop bleeding
    • patient can be addressed immediately
  • Prevents secondary bleeding.
  • Does not stick to the wound.
  • Does not disturb the normal of blood flow.
  • The present invention comprises of improved wound hygiene.
  • Useful in cases of multiple injury.
  • Can be used in surgical procedures including Vascular surgical procedures, accidental and combat field.
  • The present invention helps in earlier mobilization of the patient.
  • Can be manufactured in any size and shape as per the requirement.
  • Easy to handle.
  • Interconnected Porous in structure.
  • Packed in a laminated foil pack to protect it from environmental factors (sunlight & moisture).
  • Thermostat pack (such as Styrofoam) as an insulator and to protect a product from getting compressed during transportation or storage.
  • Multiple bandages can be applied for larger wounds.
  • Capable of use for at least 24 hours, however, haemostasis achieves within few minutes only.
  • Can be removed easily without using saline solution or water.
  • Long Shelf life at ambient temperature. Can be disposed of by burning or degradation.

Follow us @DattMediproducts to know more about these Haemostatic products. Stay tuned for our next blogs and know more about our patented products.

Visit www.dattmedi.com for more infomation.
Share:
Recent Blogs

In the realm of wound care, continuous advancements are constantly improving the way we treat and manage various types of wounds. Among the latest innovations, Velseal® -T Disc has emerged as a game-changer. This revolutionary product offers an effective and convenient solution for promoting wound healing and enhancing patient comfort.

Understanding Velseal® -T Disc

It is a cutting-edge wound care product designed to optimize the healing process while minimizing discomfort for patients. Velseal® -T Disc promotes haemostasis by absorbing the blood and accumulates clotting factor within the voids and initiate the clotting by interaction with Thrombin, Calcium chloride and Tranexamic acid.

Key Features and Benefits:

1. Advanced Composition:

It is composed of high-quality materials that offer excellent absorption and retention capacities, reducing the risk of maceration and infection. However, it does not provide moisture balance or directly contribute to wound healing.

2. Easy Application:

Thee disc-shaped design of Velseal® -T Disc allows for simple and hassle-free application. Its non-adherent nature eliminates the need for additional fixation methods, providing a secure and comfortable fit. The dressing is available in various sizes to accommodate different wound types and locations.

3. Enhanced Patient Comfort:

It prioritizes patient comfort by minimizing pain and trauma during dressing changes. The non-adherent surface prevents the dressing from sticking to the wound bed, reducing discomfort and potential damage to healing tissue.

4. Cost-Effective Solution:

It offers a cost-effective wound care solution, as it requires no dressing changes. A single application helps in achieving complete hemostasis, contributing to overall healthcare cost savings. Its durability and prolonged wear time further enhance its cost-effectiveness.

Clinical Efficacy and Evidence

The product has undergone rigorous testing and evaluation to validate its clinical efficacy. Clinical studies have demonstrated its effectiveness in promoting faster wound healing, reducing pain, and minimizing complications such as infection. These studies highlight the dressing’s superior moisture management capabilities and its ability to facilitate granulation tissue formation, resulting in improved patient outcomes.

In the rapidly evolving field of wound care, the Velseal® -T Disc stands out as a remarkable innovation. Its unique composition, easy application, and patient-centric design make it a valuable addition to any healthcare setting. With its demonstrated clinical efficacy and cost-effectiveness, this advanced dressing offers a promising solution for healthcare professionals and patients alike. By leveraging the benefits of Velseal® -T Disc, healthcare providers can enhance wound healing outcomes and improve the overall quality of care for patients with acute or chronic wounds.

In our fast-paced and demanding modern world, it has become increasingly crucial to prioritize our health and well-being. Among the myriad of health concerns affecting millions worldwide, cancer stands as one of the most significant challenges we face. However, with advances in medical science, early detection has emerged as a powerful tool in the fight against this devastating disease. In this blog, we will explore the importance of early cancer detection, shed light on screening guidelines, and emphasize the necessity of regular screenings for various types of cancer.

The Impact of Early Cancer Detection: Early detection plays a pivotal role in improving cancer outcomes and significantly increasing the chances of successful treatment. When cancer is detected in its early stages, before it has metastasized, treatment options are often less aggressive and more effective. Moreover, early detection significantly enhances survival rates, underscoring the vital importance of regular screenings for individuals.

Screening Guidelines for Different Types of Cancer:

Breast Cancer:

Among women, breast cancer is one of the most prevalent forms of the disease. The American Cancer Society advises that women aged 40 and above should undergo annual mammograms for breast cancer screening. However, individual risk factors may warrant earlier screenings or additional tests.


Colorectal Cancer:

Affecting both men and women, colorectal cancer ranks as the third most common cancer globally. Screening for colorectal cancer typically begins at the age of 45. Methods such as colonoscopy, sigmoidoscopy, and stool-based tests are employed to detect abnormal growths or cancerous cells in the colon or rectum.

Cervical Cancer:

Regular screenings and human papillomavirus (HPV) vaccination can prevent cervical cancer. The American Cancer Society recommends cervical cancer screening for individuals with a cervix starting at the age of 25. This can be achieved through a Pap test, an HPV test, or a combination of both.

Lung Cancer:

As the leading cause of cancer-related deaths worldwide, lung cancer poses a significant threat. For individuals at high risk, such as current or former smokers, low-dose computed tomography (LDCT) scans are recommended. Screening should commence at the age of 50 and continue until age 80, or as long as the individual is in good health.


Prostate Cancer:

Primarily affecting men, prostate cancer typically develops in older individuals. The American Cancer Society advises men to discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. Screening options include prostate-specific antigen (PSA) blood tests and digital rectal exams.

Early cancer detection can save lives by enabling more effective treatment options and improving survival rates. By adhering to the recommended screening guidelines for different types of cancer, individuals can take proactive steps towards their health and potentially detect cancer in its early stages.

Through raising awareness, educating the public, and advocating for regular screenings, we can work together to alleviate the burden of cancer and enhance overall healthcare outcomes. Remember, prevention and early detection are the keys to triumphing over cancer. This strategic stance promises extended lives, improved outcomes, and a brighter future for all, underscoring the vital role of early cancer detection as a beacon of hope in a world where health is paramount.

×